APA (7th ed.) Citation

J, Z., Z, C., AK, K., J, N., E, R., H, T., . . . Y, Z. (2020). Discovery of substituted 3H-pyrido[2,3-d]pyrimidin-4-ones as potent, biased, and orally bioavailable sst2 agonist. Bioorganic & medicinal chemistry letters, 30(21), 127496. https://doi.org/10.1016/j.bmcl.2020.127496

Chicago Style (17th ed.) Citation

J, Zhao, Chen Z, Kusnetzow AK, Nguyen J, Rico-Bautista E, Tan H, Betz SF, Struthers RS, and Zhu Y. "Discovery of Substituted 3H-pyrido[2,3-d]pyrimidin-4-ones as Potent, Biased, and Orally Bioavailable Sst2 Agonist." Bioorganic & Medicinal Chemistry Letters 30, no. 21 (2020): 127496. https://doi.org/10.1016/j.bmcl.2020.127496.

MLA (9th ed.) Citation

J, Zhao, et al. "Discovery of Substituted 3H-pyrido[2,3-d]pyrimidin-4-ones as Potent, Biased, and Orally Bioavailable Sst2 Agonist." Bioorganic & Medicinal Chemistry Letters, vol. 30, no. 21, 2020, p. 127496, https://doi.org/10.1016/j.bmcl.2020.127496.